跳至主要内容
临床试验/ACTRN12607000470493
ACTRN12607000470493已完成3 期

A randomised controlled clinical trial to compare the efficacy of pressurised vapocoolant and water sprays in decreasing the pain of intravenous cannulation in emergency department patients.

Austin Health0 个研究点目标入组 200 人开始时间: 2007年9月19日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
Austin Health
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 -2147483648 No limit(—)
性别
All

入选标准

  • Emergency department patients, aged 18 years or more, requiring intravenous cannulation.

排除标准

  • Refusal to provide consent; Inability to provide informed consent (Non-English speaking, altered mental state, significant illness); Moderate to severe discomfort or pain; Diseases of the skin associated with cold intolerance (eg: Raynaud’s phenomenon); Known allergy to spray contents; Peripheral neuropathy; Parenteral analgesia in the previous 4 hours

研究者

发起方
Austin Health

相似试验